KR920003691B1 - Process for the preparation of benzimidazole derivatives - Google Patents

Process for the preparation of benzimidazole derivatives Download PDF

Info

Publication number
KR920003691B1
KR920003691B1 KR1019890009913A KR890009913A KR920003691B1 KR 920003691 B1 KR920003691 B1 KR 920003691B1 KR 1019890009913 A KR1019890009913 A KR 1019890009913A KR 890009913 A KR890009913 A KR 890009913A KR 920003691 B1 KR920003691 B1 KR 920003691B1
Authority
KR
South Korea
Prior art keywords
formula
compound
methoxy
metal salt
methyl
Prior art date
Application number
KR1019890009913A
Other languages
Korean (ko)
Other versions
KR910002836A (en
Inventor
김기원
이병석
Original Assignee
일동제약 주식회사
이금기
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일동제약 주식회사, 이금기 filed Critical 일동제약 주식회사
Priority to KR1019890009913A priority Critical patent/KR920003691B1/en
Publication of KR910002836A publication Critical patent/KR910002836A/en
Application granted granted Critical
Publication of KR920003691B1 publication Critical patent/KR920003691B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

A process for preparing 5- methoxy-2-⇔4- methoxy-3,5dimethyl- 2-pyridyl) methyl! sulfinyl! benzimidazole of formula (I) and its metal salt comprises reacting an alkylthioformimidate deriv. of formula (III) with an anisole deriv. of formula (IV) to obtain a cpd. of formula (II), oxidizing (II) to form a cpd. of formula (I), and converting (I) to its metal salt. In the formulas, R=Me or Et; R1 and R2 each = Cl, Br, I or an amine gp.; one of R1 and R2 is a halogen and the other is an amine. Pref. the oxidizing agent is magnesium salt of monoperoxy phthalic acid. The cpd. (I) and its metal salt are useful as an antiulcer drug.

Description

벤즈이미다졸 유도체의 제조방법Method for preparing benzimidazole derivatives

본 발명은 구조식(Ⅰ)로 표시되는 5-메톡시-2-[[(4-메톡시-3,5-디메틸-2-피리딜)메틸]설피닐]벤즈이미다졸 및 그 금속염의 새로운 제조방법에 관한 것으로서 이 화합물은 공지의 화합물로 위산분비를 억제하며 위궤양, 십이지장궤양 및 위염을 포함하는 위장질환을 치료하는데 유용한 물질이다.The present invention provides a novel preparation of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl) methyl] sulfinyl] benzimidazole and its metal salt represented by the formula (I). As a method, the compound is a known compound that inhibits gastric acid secretion and is useful for treating gastrointestinal diseases including gastric ulcer, duodenal ulcer and gastritis.

Figure kpo00001
Figure kpo00001

상기 구조식(Ⅰ)의 화합물을 제조하는 방법은 미국 특허 제 4,255,431호, 유럽특허 제 5,129호 등에 기술되어 있으며, 이들 제조방법들은 다음과 같이 요약될 수 있다.Methods for preparing the compound of formula (I) are described in US Pat. No. 4,255,431, EP 5,129, and the like, and these preparation methods can be summarized as follows.

1. 다음 구조식(Ⅱ)의 화합물을 산화시켜서 구조식(Ⅰ)의 화합물을 얻는 방법.1. A method of obtaining the compound of formula (I) by oxidizing the compound of formula (II).

Figure kpo00002
Figure kpo00002

2. 다음 일반식(Ⅲ)의 화합물과 일반식(Ⅳ)의 화합물을 반응시켜 구조식(Ⅰ)의 화합물을 제조하는 방법.2. A method for preparing a compound of formula (I) by reacting a compound of formula (III) with a compound of formula (IV).

Figure kpo00003
Figure kpo00003

(상기 구조식에서 M는 금속으로 칼륨, 나트륨 또는 리튬이고 Z는 반응성 에스테르화 히드록시기이다)(Wherein M is potassium, sodium or lithium as the metal and Z is a reactive esterified hydroxy group)

3. 다음 일반식(Ⅴ)의 화합물과 일반식(Ⅵ)의 화합물을 반응시켜서 구조식(Ⅱ)의 화합물을 제조하고 이를 산화하여 구조식(Ⅰ)의 화합물을 제조하는 방법.3. A method of preparing the compound of formula (II) by reacting a compound of formula (V) with a compound of formula (VI) and oxidizing it to produce a compound of formula (I).

Figure kpo00004
Figure kpo00004

(상기 구조식에서 Z1, Z2중 하나는 SH(머캅토)기이고 다른 하나는 반응성 에스테르화 히드록시기이다)( One of Z 1 and Z 2 in the above formula is SH (mercapto) group and the other is a reactive esterified hydroxy group)

4. 다음 일반식(Ⅶ)의 화합물과 일반식(Ⅷ)의 화합물을 반응시켜 구조식(Ⅱ)의 화합물을 제조하고 이를 산화하여 구조식(Ⅰ)의 화합물을 제조하는 방법.4. A method for preparing a compound of formula (II) by reacting a compound of formula (VII) with a compound of formula (VII) and oxidizing it to produce a compound of formula (I).

Figure kpo00005
Figure kpo00005

상기의 제조방법들은 수율이 저조하고 구조식(Ⅲ)과 같은 금속염을 만들어야하는 등 반응조작이 번거롭고 중간체의 제조가 까다로울 뿐만 아니라 구조식(Ⅱ)의 화합물의 산화공정시 구조식(Ⅰ)의 목적화합물이 반응액속에서 미반응된 산화제에 분해되어 순수하게 얻는 것이 어려운 불편한 점이 있다.In the above methods, the yield is low and the reaction process is cumbersome, such as making a metal salt such as formula (III), and the preparation of intermediates is difficult, and the target compound of formula (I) reacts during the oxidation process of the compound of formula (II). It is difficult to obtain pure by decomposing to the unreacted oxidant in the liquid.

본 발명의 특징은 제조방법이 간단하면서 고수율 고순도로 구조식(Ⅰ) 및 그 금속염의 목적화합물을 제조함에 있다.A feature of the present invention is to prepare the target compound of the structural formula (I) and the metal salt thereof in a high yield and high purity with a simple manufacturing method.

공지의 화합물인 구조식(Ⅸ)의 3,5-디메틸-4-메톡시-2-할로메틸피리딘을 출발물질로 하여 구조식(Ⅹ)의 금속 티오시아네이트와 탄소수 C1-C3의 저급알콜 또는 DMSO, DMF, CH3CN 등과 같은 비양성자성 극성용매중에서 1-3시간동안 0℃ 내지 환류조건으로 반응시켜 높은 수득률로 구조식(XⅠ)의 3, 5-디메틸-4-메톡시-2-티오시아노메틸피리딘을 얻는다.Metal thiocyanate of formula (VII) and a lower alcohol having C 1 -C 3 as the starting material using 3,5-dimethyl-4-methoxy-2-halomethylpyridine of formula (VII) as a known compound, or 3, 5-dimethyl-4-methoxy-2-thio of formula (XI) at high yield by reaction at 0 ° C. to reflux condition for 1-3 hours in an aprotic polar solvent such as DMSO, DMF, CH 3 CN, etc. Obtain cyanomethylpyridine.

상기와 같이 제조한 구조식(XⅠ)의 화합물을 무수조건으로 탄소수 C1-C3의 저급 알콜용매, 좋기로는 메탄올 또는 에탄올 용매에 용해시킨 다음 질소기류중에서 용액을 0-10℃로 냉각시킨 후 2-5시간동안 건조염화수소 가스를 통과시키고 0-10℃에서 10-25시간동안 방치하여 반응시키면 구조식(XⅡ)의 알킬-[[2-(3,5-디메틸-4-메톡시)피리디닐]메틸티오]포름이미데이트를 높은 수율로 염산염 또는 염기상태로 얻는다.After dissolving the compound of formula (XI) prepared as described above in a low alcohol solvent, preferably methanol or ethanol, of C 1 -C 3 carbon atoms in anhydrous conditions, and then cooled the solution to 0-10 ℃ in a nitrogen stream The reaction was carried out by passing dry hydrogen chloride gas for 2-5 hours and standing at 0-10 ° C. for 10-25 hours to react with alkyl-[[2- (3,5-dimethyl-4-methoxy) pyridinyl of formula (XII). ] Methylthio] formimidate is obtained in high yield in hydrochloride or base form.

상기와 같이 제조한 구조식(XⅡ)의 화합물을 공지의 화합물인 일반식(XⅢ)의 3-아미노-4-클로로아니솔 또는 3,4-디아미노아니솔등과 메탄올, 에탄올 등과 같은 용매중에서 비교적 간단한 반응을 시키고 수산화칼륨, 수산화나트륨등과 같은 알카리 용액으로 처리하면 구조식(Ⅱ)의 화합물을 고수율로 제조할 수 있는 경제적인 방법이다. 또한 본 발명에서는 종전의 산화공정반응에서 구조식(Ⅰ)의 목적화합물이 반응액중에서 미반응된 산화제에 의해서 분해되어 순수하게 얻을 수 없는 단점을 해결하기 위하여 자극성이 없고 취급이 용이하고 산화력이 온화하여 부반응이 거의 일어나지 않으며, 물과 같은 용매에도 매우 잘 녹아 반응조건이 간편할 뿐만 아니라 반응 후 미반응된 산화제와 부산물인 마그네슘 프탈레이트를 손쉽게 제거시킬 수 있는 공지의 물질인 구조식(XⅣ)의 모노퍼옥시프탈산 마그네슘 염(MMPP)을 사용하여 구조식(Ⅱ)의 화합물을 산화시켜서 구조식(Ⅰ) 및 그 금속염의 목적화합물을 얻을때 고수율 고순도로 얻어지는 것이 본 발명의 특징이다.The compound of formula (XII) prepared as described above is relatively known in a solvent such as methanol, ethanol, and 3-amino-4-chloroanisole or 3,4-diaminoanisole of general formula (XIII), which are known compounds. A simple reaction and treatment with an alkali solution such as potassium hydroxide, sodium hydroxide, etc. is an economical way to produce the compound of formula II in high yield. In addition, in the present invention, in order to solve the disadvantage that the target compound of formula (I) is decomposed by the unreacted oxidizing agent in the reaction liquid and cannot be obtained purely in the previous oxidation process reaction, it is not irritating, easy to handle, and mild in oxidizing power. Almost no side reactions occur, and it is very well dissolved in a solvent such as water, so that the reaction conditions are simple, and monoperoxy of the formula (XIV), a known substance that can easily remove unreacted oxidant and by-product magnesium phthalate after the reaction It is a feature of the present invention to obtain a high yield and high purity when the compound of formula (II) is oxidized using magnesium phthalate salt (MMPP) to obtain the target compound of formula (I) and its metal salt.

본 발명을 화합반응식으로 도식하면 다음과 같다.Scheme of the present invention by the reaction scheme is as follows.

Figure kpo00006
Figure kpo00006

(상기 구조식에서 L는 염소, 브롬, 요오드 등의 할로겐 원소이고 M은 칼륨 또는 나트륨이며, R은 메틸, 에틸이고, R'와 R"중 하나는 염소 또는 브롬, 요오드등의 할로겐 원소이고 다른 하나는 아민기, 또는 R',R" 모두 아민기이다.)(L is a halogen element such as chlorine, bromine, iodine, M is potassium or sodium, R is methyl, ethyl, and one of R 'and R "is a halogen element such as chlorine or bromine, iodine and the other Is an amine group, or both R 'and R "are amine groups.)

이하 실시예를 들어 본 발명을 보다 상세히 설명하기로 한다.Hereinafter, the present invention will be described in more detail with reference to the following examples.

[실시예 1]Example 1

3,5-디메틸-4-메톡시-2-티오시아노메틸피리딘(XⅠ)의 제조 : 2-클로로메틸-4-메톡시-3,5-디메틸피리딘 18.56g(0.1몰)을 에탄올 100ml에 녹이고 금속 티오시아네이트 10.69g(0.11몰)을 0-5℃를 유지하며, 소량씩 30분간 가한다. 반응이 시작되면 결정이 생성되며, 0-5℃에서 30분 더 교반하고 가열하여 3시간동안 환류시키면 반응이 종결된다. 반응이 종결되면 0-5 c로 냉각시키고 여과하여 결정을 제거한 후 용매를 감압하에 증류시킨다. 잔사에 물 100ml를 가하여 녹이고 클로로포름 300ml를 2회로 나누어 추출한다. 유기층을 무수황산마그네슘으로 건조시킨 다음 감압하에서 용매를 증류시켜 표제의 화합물 19.9g(95.5%)을 얻는다.Preparation of 3,5-dimethyl-4-methoxy-2-thiocyanomethylpyridine (XI): 18.56 g (0.1 mol) of 2-chloromethyl-4-methoxy-3,5-dimethylpyridine was added to 100 ml of ethanol. Dissolve and add 10.69 g (0.11 mol) of metal thiocyanate at 0-5 ° C. in small portions for 30 minutes. Crystals are formed at the start of the reaction. The reaction is terminated by further stirring at 0-5 ° C. for 30 minutes, heating and refluxing for 3 hours. At the end of the reaction, the mixture was cooled to 0-5 c, filtered to remove crystals, and the solvent was distilled off under reduced pressure. 100 ml of water is added to the residue to dissolve it, and 300 ml of chloroform is extracted twice. The organic layer was dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure to give 19.9 g (95.5%) of the title compound.

원소분석치(C10H12N2OS)Elemental Analysis Value (C 10 H 12 N 2 OS)

이론치(%) : C ; 57.67, H ; 5.80, N ; 13.45Theoretical value (%): C; 57.67, H; 5.80, N; 13.45

실측치(%) : C ; 57.72, H ; 5.89, N ; 13,53Found (%): C; 57.72, H; 5.89, N; 13,53

[실시예 2]Example 2

메틸-[[[2-(3,5-디메틸-4-메톡시)피리미딜]메틸]티오]포름이미데이트(XⅡ)디하이드로클로라이드의 제조 :Preparation of methyl-[[[2- (3,5-dimethyl-4-methoxy) pyrimidyl] methyl] thio] formimidate (XII) dihydrochloride:

무수메탄올 80ml와 에테르160ml의 혼합용매에 3,5-디메틸-4-메톡시-2-티오시아노메틸피리딘 20.9g(0.1몰)을 용해하여 질소기류중에서 용액을 0-10℃로 냉각시킨 후 3시간 동안 염화수소가스 7.3g을 통과시키고 용액을 밀폐된 용기중에서 0-5℃를 유지하며 25시간동안 방치한다. 용매를 감압하에 증류시키고 농축잔류물에 무수에테르 150ml를 넣고 분쇄하여 무수결정으로 표제의 화합물 24.1g(76.9%)을 얻는다.After dissolving 20.9 g (0.1 mol) of 3,5-dimethyl-4-methoxy-2-thiocyanomethylpyridine in a mixed solvent of 80 ml of anhydrous methanol and 160 ml of ether, the solution was cooled to 0-10 ° C. in a nitrogen stream. Pass 7.3 g of hydrogen chloride gas for 3 hours and leave the solution for 25 hours at 0-5 ℃ in a closed container. The solvent was distilled off under reduced pressure, 150 ml of anhydrous ether was added to the concentrated residue and triturated to give 24.1 g (76.9%) of the title compound as anhydrous crystals.

원소분석치(C11H16N2O2Sㆍ 2HCI)Elemental Analysis Value (C 11 H 16 N 2 O 2 S · 2HCI)

이론치(%) : C ; 42.18, H ; 5.79, N ; 8.94Theoretical value (%): C; 42.18, H; 5.79, N; 8.94

실측치(%) : C ; 43.21, H ; 5.84, N ; 9.01Found (%): C; 43.21, H; 5.84, N; 9.01

[실시예 3]Example 3

메틸-[[[2-(3,5-디메틸-4-메톡시)피리미딜]메틸]티오]포름이미데이트(XⅡ)의 제조 :Preparation of Methyl-[[[2- (3,5-dimethyl-4-methoxy) pyrimidyl] methyl] thio] formimidate (XII):

실시예 2의 조건으로 반응시키고 난 다음 용매를 감압하에 증류시키고 농축 잔류물에 탄산칼륨 55g을 함유하는 냉각수 300ml를 붓고 혼합용액을 20% 메탄올을 함유하는 클로로포름 450ml로 3회 추출한다. 유기층을 무수황산마그네슘으로 건조시키고 용매를 감압하에 증류하여 제거하면 표제의 화합물 21.4g(89%)을 얻는다.After reacting under the conditions of Example 2, the solvent was distilled under reduced pressure, 300 ml of cooling water containing 55 g of potassium carbonate was poured into the concentrated residue, and the mixed solution was extracted three times with 450 ml of chloroform containing 20% methanol. The organic layer was dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure to give 21.4 g (89%) of the title compound.

원소분석치(C11H16N2O2S)Elemental Analysis Value (C 11 H 16 N 2 O 2 S)

이론치(%) : C ; 54.98, H ; 6.71, N ; 11.66Theoretical value (%): C; 54.98, H; 6.71, N; 11.66

실측치(%) : C ; 55.23, H ; 6.81, N ; 11.72Found (%): C; 55.23, H; 6.81, N; 11.72

[실시예 4]Example 4

5-메톡시-2-[[[4-메톡시-3,5-디메틸-2-피리딜)메틸]티오]벤즈이미다졸(Ⅱ)의 제조 :Preparation of 5-methoxy-2-[[[4-methoxy-3,5-dimethyl-2-pyridyl) methyl] thio] benzimidazole (II):

메탄올 400ml중에 메틸-[[[(2-(3,5-디메틸-4-메톡시)피리디닐]메틸]티오]포름-이미데이트(XⅡ)디하이드로클로라이드 32.9g(0.1몰)과 3-아미노-4-클로로아니솔 16.7g(0.106몰)을 넣고 실온에서 18시간 교반한 다음 6시간 동안 환류시킨다. 0-10℃로 냉각후 혼합물에 수산화나트륨 용액(8.2g/160ml의 물)을 서서히 가하고 생성된 혼합물을 80분동안 더 환류시킨다. 반응이 완결되면 감압하에 증류하여 메탄올을 제거하고 잔류물에 얼음물 200ml를 추가하여 녹인 다음 클로로포름 600ml를 2회로 나누어 추출한다. 유기층을 무수황산마그네슘으로 건조하여 여과하고 감압하에 용매를 제거한다. 잔류물에 아세톤 200ml와 물 30ml를 가하여 녹이고 여기에 17.5% 염산 수용액 21ml를 10-20℃에서 20분동안 가하고 0-5℃로 냉각하여 2시간 교반하면 결정이 생성된다. 생성된 결정을 여과하고 아세톤 30ml로 세척한 후 건조하면 표제의 화합물을 염산염으로 27g 얻는다.32.9 g (0.1 mol) of methyl-[[[(2- (3,5-dimethyl-4-methoxy) pyridinyl] methyl] thio] formimide (XII) dihydrochloride and 3-amino in 400 ml of methanol 16.7 g (0.106 mol) of -4-chloroanisole was added and stirred at room temperature for 18 hours, and then refluxed for 6 hours After cooling to 0-10 ° C., sodium hydroxide solution (8.2 g / 160 ml of water) was slowly added to the mixture. The resulting mixture was further refluxed for 80 minutes, and when the reaction was completed, the mixture was distilled under reduced pressure to remove methanol, dissolved in 200 ml of ice water, and extracted with 600 ml of chloroform twice. Filter and remove the solvent under reduced pressure, add 200 ml of acetone and 30 ml of water to the residue, dissolve it, add 21 ml of 17.5% aqueous hydrochloric acid solution at 10-20 ℃ for 20 minutes, cool to 0-5 ℃, and stir for 2 hours. The resulting crystals are filtered off Washing with 30 ml tons and drying gives 27 g of the title compound as hydrochloride.

위에서 얻은 염산염 27g을 물 100ml에 녹이고 클로로포름 300ml를 가한다. 교반하면서 15% 탄산나트륨 수용액 115ml를 가하여 중화시키고 유기층을 분리한다. 무수황산 마그네슘으로 건조하여 여과하고 감압하에 증류하여 용매를 제거한 다음 농축 잔류물에 메틸에틸케톤 60ml를 가하여 녹이고 석유에테르를 서서히 가하여 준 후 0-5 ℃로 냉각하여 5시간 교반하여 결정을 생성시킨다. 생성된 결정을 여과한 후 에테르 30ml로 세척하고 건조하여 표제의 화합물 21g(63.7%)을 백색결정으로 얻었다.Dissolve 27 g of the hydrochloride obtained above in 100 ml of water and add 300 ml of chloroform. While stirring, 115 ml of 15% aqueous sodium carbonate solution is added to neutralize and the organic layer is separated. After drying over anhydrous magnesium sulfate, filtration, distillation under reduced pressure to remove the solvent, 60 ml of methyl ethyl ketone was added to the concentrated residue to dissolve, petroleum ether was slowly added, cooled to 0-5 ° C. and stirred for 5 hours to form crystals. The resulting crystals were filtered off, washed with 30 ml of ether and dried to give 21 g (63.7%) of the title compound as white crystals.

융점 : 118-123℃Melting Point: 118-123 ℃

Figure kpo00007
: 3,341, 1,212, 1,167
Figure kpo00007
: 3,341, 1,212, 1,167

1H-NMR(CDCI3)δ: 2.06(s,3H), 2.11(s,3H), 3.56(s,3H), 3.65(s,3H), 4.72(s,2H), 6.6-7.5(m,3H), 8.16(s,1H) 1 H-NMR (CDCI 3 ) δ: 2.06 (s, 3H), 2.11 (s, 3H), 3.56 (s, 3H), 3.65 (s, 3H), 4.72 (s, 2H), 6.6-7.5 (m , 3H), 8.16 (s, 1H)

[실시예 5]Example 5

5-메톡시-2-[[4-메톡시-3,5-디메틸-2-피리딜)메틸]티오]벤즈이미다졸(Ⅱ)의 제조 :Preparation of 5-methoxy-2-[[4-methoxy-3,5-dimethyl-2-pyridyl) methyl] thio] benzimidazole (II):

메탄올 40ml중에 메틸-[[[(2-(3,5-디메틸-4-메톡시)피리디닐]메틸]티오]포름-이미데이트(XⅡ)디하이드로클로라이드 3.29g(0.01몰)과 3,4-디아미노아니솔하이드로클로라이드 1.75g(0.01몰)의 혼합물을 실온에서 20시간 교반하여 반응시킨다. 혼합물에 수산화나트륨용액(1.3g/20ml의 물)을 가하고 생성된 혼합물을 1시간동안 환류시킨다. 반응이 완결되면 실시예 4와 같은 방법으로 처리하여 표제의 화합물 2.4g(73%)을 얻는다.3.29 g (0.01 mol) and 3,4 of methyl-[[[(2- (3,5-dimethyl-4-methoxy) pyridinyl] methyl] thio] form-imdate (XII) dihydrochloride in 40 ml of methanol -A mixture of 1.75 g (0.01 mol) of diaminoanisole hydrochloride is reacted by stirring at room temperature for 20 hours, to which sodium hydroxide solution (1.3 g / 20 ml of water) is added and the resulting mixture is refluxed for 1 hour. Upon completion of the reaction, the reaction was carried out in the same manner as in Example 4 to obtain 2.4 g (73%) of the title compound.

융점 : 119-123℃Melting Point: 119-123 ℃

Figure kpo00008
: 3,341, 1,212, 1,167
Figure kpo00008
: 3,341, 1,212, 1,167

1H-NMR(CDCI3)δ: 2.06(s,3H), 2.11(s,3H), 3.56(s,3H), 3.65(s,3H), 4.72(s,2H), 6.6-7.5(m,3H), 8.16(s,1H) 1 H-NMR (CDCI 3 ) δ: 2.06 (s, 3H), 2.11 (s, 3H), 3.56 (s, 3H), 3.65 (s, 3H), 4.72 (s, 2H), 6.6-7.5 (m , 3H), 8.16 (s, 1H)

[실시예 6]Example 6

5-메톡시-2-[[4-메톡시-3,5-디메틸-2-피리딜)메틸]설피닐]벤즈이미다졸(Ⅰ)의 제조 :Preparation of 5-methoxy-2-[[4-methoxy-3,5-dimethyl-2-pyridyl) methyl] sulfinyl] benzimidazole (I):

물 150ml중에 90% 모노퍼옥시프탈산마그네슘염 육수화물 30g(0.055몰)을 녹인 용액을 5-메톡시-2-[[(4-메톡시-3,5-디메틸-2-피리딜)메틸]티오]벤즈이미다졸 32.9g(0.1몰)을 에탄올 60ml에 녹인 용액에 실온에서 3분동안 가하고 혼합액을 45-50℃에서 2시간 교반하여 반응시킨다. 반응이 완결되면 0-5℃로 냉각하고 20% 탄산나트륨 수용액 38ml를 서서히 가하여 주고 혼합액을 클로로포름 400ml를 2회로 나누어 추출한다. 유기층을 -5-0℃에서 무수황산마그네슘으로 건조하여 여과하고 용매를 10℃이하의 온도에서 감압증류하여 제거한다. 잔류물에 아세토니트릴 120ml를 가하고 -5-0℃에서 1시간 교반하여 결정을 생성시키고 여과한다. 여과된 결정을 아세토니트릴 10ml, 에테르 20ml로 세척하고 30℃에서 5시간 감압건조하여 표제의 화합물 33.2g(96%)을 백색결정으로 얻는다.A solution of 30 g (0.055 mol) of 90% monoperoxyphthalic acid salt hexahydrate in 150 ml of water was dissolved in 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl) methyl]. 32.9 g (0.1 mol) of thio] benzimidazole was added to a solution of 60 ml of ethanol at room temperature for 3 minutes, and the mixture was stirred at 45-50 ° C. for 2 hours to react. After the reaction was completed, the mixture was cooled to 0-5 ° C., and 38 ml of 20% aqueous sodium carbonate solution was slowly added thereto, and the mixture was extracted with two portions of 400 ml of chloroform. The organic layer was dried over anhydrous magnesium sulfate at -5-0 占 폚, filtered, and the solvent was removed by distillation under reduced pressure at a temperature of 10 占 폚 or lower. 120 ml of acetonitrile were added to the residue, and stirred for 1 hour at -5-0 ° C to produce crystals and filtered. The filtered crystals were washed with 10 ml of acetonitrile and 20 ml of ether and dried under reduced pressure at 30 ° C. for 5 hours to give 33.2 g (96%) of the title compound as white crystals.

융점 : 154-156℃Melting Point: 154-156 ℃

Figure kpo00009
: 1,413, 1,211, 1,023
Figure kpo00009
: 1,413, 1,211, 1,023

1H-NMR(CDCℓ3+DMSO-d6)δ: 2.10(s,3H), 2.13(s,3H), 3.60(s,3H), 3.76(s,3H), 4.6(s,2H), 6.68-7.58(m,3H), 8.16(s,1H) 1 H-NMR (CDCℓ 3 + DMSO-d 6 ) δ: 2.10 (s, 3H), 2.13 (s, 3H), 3.60 (s, 3H), 3.76 (s, 3H), 4.6 (s, 2H), 6.68-7.58 (m, 3H), 8.16 (s, 1H)

[실시예 7]Example 7

5-메톡시-2-[[(4-메톡시-3,5-디메틸-2-피리딜)에틸]설피닐]벤즈이미다졸나트륨염의 제조 :Preparation of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl) ethyl] sulfinyl] benzimidazole sodium salt:

NaOH 4g(0.1몰)을 탈이온수 10ml에 녹인 용액과 테트라하이드로푸란 350ml를 섞은 혼합용액을 격렬하게 교반하면서 5-메톡시-2-[[(4-메톡시-3,5-디메틸-피리딜)메틸]설피닐]벤즈이미다졸(Ⅰ) 34.5g(0.1몰)을 가한뒤 1시간동안 계속 교반한다. 혼합물에 이소프로판올 160ml를 추가하고 실온에서 18시간 교반한다. 혼합물을 0-5℃로 냉각시켜 3.5시간 더 교반한 후 결정을 여과하여 이소프로판올 100ml로 세척한다. 여과된 결정을 감압하에 45℃에서 5시간 건조하면 표제의 화합물 35.3g(96%)을 얻는다.A solution of NaOH 4g (0.1 mol) dissolved in 10 ml of deionized water and 350 ml of tetrahydrofuran were mixed with vigorous stirring while 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-pyridyl 34.5 g (0.1 mol) of methyl] sulfinyl] benzimidazole (I) is added and stirring is continued for 1 hour. Add 160 ml of isopropanol to the mixture and stir at room temperature for 18 hours. The mixture is cooled to 0-5 ° C. and stirred for another 3.5 hours, after which the crystals are filtered and washed with 100 ml of isopropanol. The filtered crystals were dried at 45 ° C. for 5 hours under reduced pressure to afford 35.3 g (96%) of the title compound.

융점 : 207-210℃Melting Point: 207-210 ℃

1H-NMR(D6O)δ : 1.86(s,3H), 2.1(s,3H), 3.51(s,3H), 3.86(s,3H), 4.75(s,2H), 6.84(dd,1H), 7.3(d,1H), 7.56(d,1H), 8.16(d,1H) 1 H-NMR (D 6 O) δ: 1.86 (s, 3H), 2.1 (s, 3H), 3.51 (s, 3H), 3.86 (s, 3H), 4.75 (s, 2H), 6.84 (dd, 1H), 7.3 (d, 1H), 7.56 (d, 1H), 8.16 (d, 1H)

[실시예 8]Example 8

5-메톡시-2-[[4-메톡시-3,5-디메틸-2-피리딜)메틸]설피닐]벤즈이미다졸 칼륨염의 제조 :Preparation of 5-methoxy-2-[[4-methoxy-3,5-dimethyl-2-pyridyl) methyl] sulfinyl] benzimidazole potassium salt:

KOH 5.6g(0.1몰)을 이소프로판올 300ml에 녹인 용액을 격렬하게 교반하면서 5-메톡시-2-[[(4-메톡시-3,5-디메틸-2-피리딜)메틸]설피닐]벤즈이미다졸(Ⅰ)34.5g(0.1몰)을 가한 뒤 30분동안 계속 교반한다. 혼합물에 이소프로판올 200ml를 추가하고 실온에서 2시간 더 교반한다. 용매를 감압하에 증류하여 제거하고 디클로로메탄 300ml와 탈이온수 400ml를 넣어 20분 교반하고 층분리를 하여 물층은 디클로로메탄 100ml로 1회 세척한 후 셀라이트로 여과한다. 여액을 감압증발하여 제거하고 초산에틸 250ml로 재결정하여 표제의 화합물 35.7g(93.1%)를 얻는다.5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl) methyl] sulfinyl] benz with vigorous stirring of a solution of 5.6 g (0.1 mol) of KOH in 300 ml of isopropanol 34.5 g (0.1 mol) of imidazole (I) was added and stirring continued for 30 minutes. Add 200 ml of isopropanol to the mixture and stir for another 2 hours at room temperature. The solvent was distilled off under reduced pressure, 300 ml of dichloromethane and 400 ml of deionized water were added and stirred for 20 minutes. The layers were separated, washed once with 100 ml of dichloromethane, and filtered through celite. The filtrate was removed by evaporation under reduced pressure and recrystallized with 250 ml of ethyl acetate to obtain 35.7 g (93.1%) of the title compound.

융점 : 147-150℃Melting Point: 147-150 ℃

[실시예 9]Example 9

디-5-메톡시-2-[[4-메톡시-3,5-디메틸-2-피리딜)메틸]설피닐]벤즈이미다졸 마그네슘염의 제조 :Preparation of Di-5-methoxy-2-[[4-methoxy-3,5-dimethyl-2-pyridyl) methyl] sulfinyl] benzimidazole magnesium salt:

무수에탄올 70ml에 CCI41ml를 가하고 교반하면서 마그네슘 1.2g(0.05몰)을 가하여 녹인 용액을 5-메톡시-2-[[(4-메톡시-3,5-디메틸-2-피리딜)메틸]설피닐]벤즈이미다졸(Ⅰ) 34.5g(0.1몰)을 에탄올 700ml에 녹인 용액에 소량씩 30분간 적가하고 실온에서 30분간 더 교반시킨 다음 용매를 감압증류하고 생성된 결정을 건조하면 표제의 화합물 31.4g(88%)를 결정성 고체로 얻는다.1 ml of CCI 4 was added to 70 ml of anhydrous ethanol, and 1.2 g (0.05 mol) of magnesium was added while stirring to dissolve the solution. 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl) methyl ] Sulfinyl] benzimidazole (I) 34.5g (0.1 mol) was added dropwise to the solution dissolved in 700 ml of ethanol for 30 minutes in small portions, stirred for 30 minutes at room temperature, the solvent was distilled under reduced pressure and the resulting crystals were dried. 31.4 g (88%) of compound are obtained as a crystalline solid.

융점 : 178-179℃Melting Point: 178-179 ℃

[실시예 10]Example 10

디-5-메톡시-2-[[(4-메톡시-3,5-디메틸-2-피리딜)메틸]설피닐]벤즈이미다졸 칼슘염 이수염의 제조 :Preparation of Di-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl) methyl] sulfinyl] benzimidazole calcium salt dihydrate:

탈이온수 60ml에 무수 CaC125.5g(0.05몰)을 녹인 용액을 탈이온수 400ml에 5-메톡시-2-[[(4-메톡시-3,5-디메틸-2-피리딜)메틸]설피닐]벤즈이미다졸 나트륨염 36.7g(0.1몰)을 녹인 용액에 격렬하게 교반하면서 소량씩 10분간 적가하고 실온에서 40분간 더 교반한다. 생성된 침전을 여과하고 탈이온수 500ml로 충분히 세척하여 실온에서 건조시킨 다음 분쇄하여 45℃에서 15시간 진공건조시키면 표제의 화합물 32.5g(85%)를 얻는다.A solution of 5.5 g (0.05 mol) of anhydrous CaC1 2 dissolved in 60 ml of deionized water was added to 400 ml of deionized water. 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl) methyl] sulphi To a solution of 36.7 g (0.1 mole) of sodium] benzimidazole sodium salt was added dropwise in small portions for 10 minutes with vigorous stirring and further stirred at room temperature for 40 minutes. The resulting precipitate was filtered, washed sufficiently with 500 ml of deionized water, dried at room temperature, triturated and vacuum dried at 45 ° C. for 15 hours to give 32.5 g (85%) of the title compound.

융점 : 180-183℃Melting Point: 180-183 ℃

1H-NMR(CDCℓ3+DMSO-d6)δ : 1.99(s,3H), 2.14(s,3H), 3.6(s,3H), 3.58(s,3H), 3.69(s,3H), 4.47(s,2H), 6.7(dd,1H), 7.1(d,1H), 7.59(d,1H), 8.14(s,1H) 1 H-NMR (CDCℓ 3 + DMSO-d 6 ) δ: 1.99 (s, 3H), 2.14 (s, 3H), 3.6 (s, 3H), 3.58 (s, 3H), 3.69 (s, 3H), 4.47 (s, 2H), 6.7 (dd, 1H), 7.1 (d, 1H), 7.59 (d, 1H), 8.14 (s, 1H)

Claims (5)

일반식(XⅡ) 알킬티오포름이미데이트 유도체와 일반식(XⅢ)의 아니솔 유도체를 반응시켜서 구조식(Ⅱ)의 화합물을 제조하고 이를 산화반응시켜서 구조식(Ⅰ)의 목적화합물을 제조하고, 얻어진 구조식(Ⅰ)의 목적화합물을 통상의 방법으로 금속염으로 전환시킴을 특징으로 하는 구조식(Ⅰ)의 화합물 및 그 금속염을 제조하는 방법.A compound of formula (II) is prepared by reacting an alkylthioformimidate derivative of general formula (XII) with an anisole derivative of general formula (XIII), followed by oxidation to prepare a target compound of structural formula (I). A method for producing a compound of formula (I) and a metal salt thereof, characterized by converting the target compound of (I) to a metal salt in a conventional manner.
Figure kpo00010
Figure kpo00010
상기 구조식에서 R은 메틸, 에틸기를 나타내며, R'와 R"중 하나는 염소, 브롬, 요오드등의 할로겐 원소이고, 다른 하나는 아민기, 또는 R',R" 모두 아민기이다.)In the above structural formula, R represents methyl and ethyl group, one of R 'and R "is a halogen element such as chlorine, bromine, iodine, and the other is an amine group or R', R" are both amine groups.)
제 1항에 있어서, 구조식(Ⅱ)의 화합물의 산화 반응시 산화제로 하기 구조식(XⅣ)의 모노퍼옥시프탈산 마그네슘염을 사용하여 구조식(Ⅰ)의 화합물을 제조하는 방법.The process of claim 1, wherein the compound of formula (I) is prepared using a monoperoxy phthalate magnesium salt of formula (XIV) as an oxidant in the oxidation reaction of the compound of formula (II).
Figure kpo00011
Figure kpo00011
제 1항에 있어서 구조식(XⅡ)의 화합물은 하기 일반식(Ⅸ)의 화합물과 일반식(Ⅹ)의 화합물을 반응시켜 구조식(XⅠ)의 화합물을 제조하고, 여기에 메탄올, 에탄올등의 용액중에서 염화가스를 반응시켜 제조하는 방법.The compound of formula (XII) according to claim 1, wherein the compound of formula (XII) is reacted with a compound of formula (X) to prepare a compound of formula (XI), which is dissolved in a solution such as methanol or ethanol. Method for producing by reacting chlorine gas.
Figure kpo00012
Figure kpo00012
(상기 구조식에서 L는 염소, 브롬 혹은 요오드를 나타내고 M은 칼륨 또는 나트륨 원소를 나타낸다.)(Wherein L represents chlorine, bromine or iodine and M represents potassium or sodium element).
제 1 항에 있어서, 구조식(Ⅰ)의 금속염을 제조하는 방법.The method of claim 1, wherein the metal salt of formula (I) is prepared. 제 4 항에 있어서, 금속염은 Na+, K+, Mg+2, Ca+2인 것을 특징으로 하는 방법.The method of claim 4 wherein the metal salt is Na + , K + , Mg +2 , Ca +2 .
KR1019890009913A 1989-07-12 1989-07-12 Process for the preparation of benzimidazole derivatives KR920003691B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890009913A KR920003691B1 (en) 1989-07-12 1989-07-12 Process for the preparation of benzimidazole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019890009913A KR920003691B1 (en) 1989-07-12 1989-07-12 Process for the preparation of benzimidazole derivatives

Publications (2)

Publication Number Publication Date
KR910002836A KR910002836A (en) 1991-02-26
KR920003691B1 true KR920003691B1 (en) 1992-05-09

Family

ID=19288046

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890009913A KR920003691B1 (en) 1989-07-12 1989-07-12 Process for the preparation of benzimidazole derivatives

Country Status (1)

Country Link
KR (1) KR920003691B1 (en)

Also Published As

Publication number Publication date
KR910002836A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
CA1234118A (en) Pyridyl-n-oxide intermediates for the preparation of omeprazole
EP2186807B1 (en) Process for the preparation of esomeprazole magnesium dihydrate
CA1066711A (en) Thiophene derivatives
KR920003691B1 (en) Process for the preparation of benzimidazole derivatives
KR20030060901A (en) A process for the preparation of pantoprazole and intermediates therefor
KR0130975B1 (en) Method for the preparation of herbicidal o-carboxyarylimidazolinone compounds
US20060142595A1 (en) Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI
KR860001995B1 (en) Process for the preparation of urea derivation to thio urea derivation
US5539107A (en) Method for the production of azaphenothiazines
KR960011390B1 (en) Processes for preparation of benzimidazole derivatives
KR890001404B1 (en) Process for preparing benzimidazole derivatives
KR880001048B1 (en) Process for the preparation of azetidinesulfonic acids
JPS6094979A (en) Novel preparation of 1,2,3-trithiane derivative
KR960002912B1 (en) Novel benzimidazole derivative
US5162534A (en) Process for the preparation of thiazoline derivatives
KR920007270B1 (en) Method of preparing for pyridine
KR910009956B1 (en) Process for preparation of benzimidazol derivatives
US4294970A (en) Oxidation of alpha-alkylated, benzyl-substituted 2-thiopyridine 1-oxides
GB1570912A (en) Aromatic sulphonamido derivatives and process for their manufacture
HU194815B (en) Process for preparing n-arylformamidine derivatives
KR860000591B1 (en) Process for preparing pyridine carboxylic acid derivatives
US4024136A (en) Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
KR890004198B1 (en) Process for preparing 3-pyridine propanoic acid derivatives
KR900003399B1 (en) Process for preapring pyridyl and quinolyl imidazolinones
JP2536755B2 (en) Anthranilic acid derivative

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
O035 Opposition [patent]: request for opposition

Free format text: OPPOSITION NUMBER: 001992001367; OPPOSITION DATE: 19920624

O035 Opposition [patent]: request for opposition

Free format text: OPPOSITION NUMBER: 001992001723; OPPOSITION DATE: 19920709

E701 Decision to grant or registration of patent right
O073 Decision to grant registration after opposition [patent]: decision to grant registration
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee